chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Migraine headaches; This is a spontaneous report from a contactable consumer (parent). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: FA6780, expiration date was not reported), via an unspecified route of administration on 31Jul2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. There is a Product Complaint. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. It was reported that, the reporters other child has continue to have headache since during the second shot migraine headaches since the second vaccine. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Tested positive for Paxlovid/fully vaccinated. I've had 3 doses of the vaccine; Tested positive for Paxlovid/fully vaccinated. I've had 3 doses of the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2022, outcome "unknown" and all described as "Tested positive for Paxlovid/fully vaccinated. I've had 3 doses of the vaccine". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2022) Positive, notes: she tested positive for Paxlovid and started taking Paxlovid this sunday. Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient stated this was not a complaint at all. However, patient would like to suggest a few things. The local doctors don't know how to prescribe the drugs correctly. Patient did her research before taking Paxlovid and I had to stop taking my statins and the drug she takes for her rheumatoid arthritis. Her regular internist didn't know they interacted with Paxlovid". "Local doctors on the ground need better education. It's like the wild west right now". Patient stated that she tested positive for Paxlovid and started taking Paxlovid this sunday. However, a couple of hours ago (12Apr2022) she noticed that her urine was turning a different color. Patient reported that she was fully vaccinated. She had 3 doses of the vaccine.  The information on the batch/lot number for COVID-19 Vaccine - Manufacturer Unknown has been requested and will be submitted if and when received.
Hep B & Tdap given 4/13/11 with one vaccine in each arm. On 4/14/11, patient experienced redness & itching in both arms. She walked into clinic on 4/19/11 because redness had increased. Presented with erythema in both upper extremities from mid deltoid to 1" below elbow. Treated with prednisone 40mg x 2 days, 30mg x 2 days & 20mg po x 2 days.
around 1106am patient complained of "harsh" throat and "just not feeling right" EMS on scene performed EKG  11:10am patient had emesis, 118/72, HR-76, 98% on room air, PA evaluated pt on site and ordered Hydroxyzine 25mg po x1. pt took this and has no complaints.
This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, route and dose were unknown). On an unknown date, the patient had a line below the injection site after getting ZOSTAVAX. The patient was treated with BENADRYL. The outcome of the event was unknown. Additional information is not expected.
rash on arms & severe on neck;noticed on 5/12/99 or 5/13/99;kept getting worse put cortaid on it & gave antihistamine;took to ER 5/16/99;MD started IV & also later gave shot;pt on med for four days;
I developed a headache the day of the vaccine.  The headache however has persisted intermittently for several weeks since the vaccination. The headaches are not daily and are generally mild to moderate.  I have had to take Aleve on occasion.  What is unusual is that I rarely used to get headaches.
Pt 44 F with no past medical history.  though her 2nd  Pfizer dose in our healthcare computer system is 7/2021, she reports having another Covid shot (booster?) perhaps at another facility, around 11/2021. Reports about 1 month later, development of symptoms: intensified daily hot flashes (prior had very mild hot flashes x 2 years), weight loss, hair loss, palpitations, tremulous ness. Found to have secondary amenorrhea (LMP 12/8/21, prior menses was regular) and newly dx hyperthyroidism (1/2022). I am an endocrinologist and saw her for first time in clinic 2/11/2022; running labs, suspect Graves? disease. Also, Her mother had menopause at age 50.
3/8/21  - Hives started day after shot on right hand.  Thought was bug bite.  Proceeded to get them on my right hip, lower back and buttocks, upper shoulder blades, right foot. left wrist during week. Called doctor and was advised to take benadryl right away and to not go for second dosage on April 11.   By Saturday morning, March 13, a hive under each eye, one on back of neck, upper lip started to swell and tingle.  Went to ER  in a.m. on March 13 and was given injection of benadryl, pepcid and a steriod.  Script was written for predisone, 2 a day with meals until this Wednesday.      Hives have cleared up.
Pain after pneumococcal 13-val conj vac (dipht crm197 protein) injection/ pain on the same side of injection, left arm, near shoulder, forearm/ pain in his muscle; difficulty sleeping on his left side; This is a spontaneous report from a contactable pharmacist (patient). A 73-year-old-male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) solution for injection in pre-filled syringe (Batch/lot number: DL2861, NDC number of Prevnar 13: 00005-1971-02) intramuscularly in the left deltoid on 19Nov2020 12:00 around noon at 0.5ml single as routine pneumonia vaccine. Medical history was none. Concomitant medications were none. Patient reported that previously in 2014 he took an unknown pneumonia vaccine (states he is not sure what the name was) and a zoster shingles vaccine in separate arms. He took the flu vaccine in 2014 not at the same time but around that time. He had a flu vaccine last year (2019). He never had any pain reaction from the previous vaccines he had administered. Patient took pneumococcal 13-val conj vac (dipht crm197 protein) at a Pharmacy. He was told by the pharmacist to follow up and take a dose of pneumonia vaccine 23, pneumovax 23 a year after receiving the pneumococcal 13-val conj vac (dipht crm197 protein). Patient experienced pain after pneumococcal 13-val conj vac (dipht crm197 protein) injection on 19Nov2020. The pain started 3 or 4 hours after the injection. The pain had lasted more than 3 weeks. He did not know if his bone was hit from the injection. The pain was on the same side of injection, left arm, near shoulder, forearm. It was painful, not serious, not life threatening. He had never had this happen with any prior vaccine. He was really shock that the pain in his muscle continued this long. He had difficulty sleeping on his left side for many days due to the pain (Nov2020). He tried to do hand movement exercise for days and when there was more pain he took one tablet of prescription ibuprofen (MOTRIN) 600mg twice a day. Pain has gradually improved. No emergency room visit and no physician office visit. Investigation assessment was no. The outcome of event "Pain after pneumococcal 13-val conj vac (dipht crm197 protein) injection/ pain on the same side of injection, left arm, near shoulder, forearm/ pain in his muscle" was recovering. The outcome of event "difficulty sleeping on his left side" was unknown. The patient considered the event was related to pneumococcal 13-val conj vac (dipht crm197 protein).  No follow-up attempts are needed. No further information is expected.
Hives/ Raised welts; General itch; This is a spontaneous report from a contactable consumer. This consumer reported for a 77-Year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9265 and expiry date was not reported), via an unspecified route of administration, on 27Feb2021 (age at vaccination: 77 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9263 and expiry date was not reported), via an unspecified route of administration, on 01Feb2021, as a single dose for COVID-19 immunization. This patient encountered hives on the second injection (intermittent with raised welts at random locations with a general itch for 3-4 days) on an unspecified date in 2021 which she treated with Benadryl. The question was she able to receive the booster vaccine since she reacted on the second injection. Outcome of the events was recovered on an unspecified date in 2021.
Patient reports she received the Moderna Covid 19 vaccine lot number 039K20A on 12/31/2020 in her right deltoid. She received the vaccine at clinic. Patient reports on 1/12/2021 she noted an approximate 4 inch x 2 inch area, red, warm to touch, raised and dull ache at injection site.  Patient reports she applied cold compress. Patient reports improvement in redness and soreness on 1/14/2021. VAERS completed. Follow up on 1/15/2021.
Narrative: Patient reported feeling short of breath and chest pain about a week following administration of 1st dose of pfizer vaccine. Patient was advised to seek emergency medical attention. Unclear if patient did, no outside notes documented. Patient did received second dose of pfizer covid vaccine without issue.
No further AE details; HBP called to report that a child was given PROQUAD that expired on 6/9/2023. Date of administration: 6/12/23. No symptoms reported. HBP does not have HCP information, as this was a report that she received with limited data. HCP declines permission; This spontaneous report was received and refers to a 4-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 12-JUN-2023, the patient was vaccinated with an expired dose (expired dose: 09-JUN-2023) of measles, mumps, rubella and varicella (OKA-MERCK) virus vaccine live (PROQUAD) (Lot number U0392539 is an invalid lot number for PROQUAD) 0.5 milliliter, administered for prophylaxis (strength, anatomical location and route of administration were not provided). No additional adverse event was reported.
Vaccine administered at 1845.  Noted leg to be red and swollen over night.  By morning, area deeper red/ purple with blisters and sloughing noted.
became totally nauseous; light headed; very chilled; extremely tired; very cold; Fell asleep under warm down quilt until 2:00pm (total 13 hours sleep); This is a spontaneous report from a contactable consumer reporting for herself. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot number en5318, Expiry date not reported) via an unspecified route of administration to left arm on 26Jan2021 08:15 at single dose for covid-19 immunization. Medical history included UTI (urinary tract infection), rosacea, severe breathing problems, no sense of taste or smell, severe bronchitis, pneumonia, productive cough (productive cough that lasted for 2 months) and known allergies: some eye drops; some pain killers (nausea). The patient became totally nauseous, light headed, very chilled, extremely tired, very cold, fell asleep under warm down quilt until 2:00pm (total 13 hours sleep) all on 31Jan2021. The events were reported as non-serious. Reporter states she Woke up 8:00 am and dressed. Felt fine until 9:00. Had some milk tea and 2 morning pills and became totally nauseous and light headed. Went back to bed immediately. Became very chilled, and extremely tired. Checked temperature at 97.5 and was very cold. Fell asleep under warm down quilt until 2:00pm (total 13 hours sleep). Felt better, but ate little and wore a coat inside. After a light dinner, nausea mostly gone, but still tired. Reporter added that she almost certainly had a serious case of Covid in early February, 2020. Nobody knew the symptoms, so both urgent care and the ER sent her home with minimal treatment. She had severe breathing problems, no sense of taste or smell, severe bronchitis with some pneumonia (X-ray), and a productive cough that lasted for 2 months. The patient underwent lab tests and procedures which included body temperature: 97.5 (Unit unspecified) on 31Jan2021 and x-ray: some pneumonia on an unspecified date. No treatment was received for the adverse event. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. Outcome of the events was recovering.
R eye was swollen on lower eyelid & sclera glossy. Began approximately 45 mins. after vaccines were administered. Consulted with doctor and advised mother to go to ER -. No treatment given.
After the 1st dose, she noticed a spike, like manifest, of her condition (OCD); After the 1st dose, she described her symptom as she'd need to dump the pitcher 3 or 4 times as she thought it was contaminated.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Aug-2021 and was forwarded to Moderna on 23-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (After the 1st dose, she noticed a spike, like manifest, of her condition (OCD)) and FEELING ABNORMAL (After the 1st dose, she described her symptom as she'd need to dump the pitcher 3 or 4 times as she thought it was contaminated.) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included Brain injury. Concurrent medical conditions included Obsessive-compulsive disorder (Patient had OCD like germaphobia for the past 30+ years and it was manageable and under control).    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (After the 1st dose, she noticed a spike, like manifest, of her condition (OCD)) and FEELING ABNORMAL (After the 1st dose, she described her symptom as she'd need to dump the pitcher 3 or 4 times as she thought it was contaminated.). At the time of the report, CONDITION AGGRAVATED (After the 1st dose, she noticed a spike, like manifest, of her condition (OCD)) and FEELING ABNORMAL (After the 1st dose, she described her symptom as she'd need to dump the pitcher 3 or 4 times as she thought it was contaminated.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was taking a lot of medication but declined providing the medication list.  Treatment information was not provided.   This case was linked to MOD-2021-294492 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received on 01-Sep-2021 and contains non-significant information.
pt recvd vax 17AUG94 & c/o pain in lt arm radiating to breast; also c/o palpatations; lt arm was red & warm to touch @ inject site lt arm was edematous; underneath arm was swollen
She developed shingles (Acute Herpes Zoster) 21 months after receiving her ZOSTAVAX. No complications.
itching/rash and hives coming and going mainly on head, neck, chest, back, stomach, arms and hands. Symptoms started around 11/15/2021 2 weeks after receiving my moderna booster. Symptoms have yet to subside. Nurse Practitioner seen on 11/22 for symptoms told me to double up on Allegra for a few days which I did and stated I could try Pepcid which I have not yet done. Still no relief.
Violent diarrhea lasted almost 8 hours. Extreme nausea and fatigue lasted almost 2 days. Severe arm pain after 2 days
Patient received his annual flu vaccine, shortly afterwards (about 15 minutes), mom reported patient had fainted outside on way to their vehicle.  Emergency action initiated, 911/ems called, RPh (myself) arrived on scene outside with emergency kit (children epipen, bp meter), pt found awake and responsive and sitting, patient reported feeling weak/dizzy (like in a dream), Pulse found elevated, no signs of rash/swelling/trouble breathing, EMS/Firefighters arrived at this point (post 20 minutes from time of vaccination), found everything WNL except BP showed being low (upper 80s/60s), Ambulance arrived 5 min later, found everything WNL (Blood sugar 95, oxygen 96), determined episode due to anxiousness, child okayed to release/parents denied visit to hospital, said they would follow-up with pediatrician.
Sore neck, throat and tongue. Fatigue. Body aches. Soreness at site of injection. Nausea. Continuing through today, 12/30/2010
Patient reported headache and swelling  and itching of his face. He declined treatment (diphenhydramine) or staying longer to be monitored. Noted itching was decreasing before leaving at end of 30min monitoring - left clinic alert and otherwise well enough to contact someone familiar to him should symptoms become worse per clinic nurse.
Information has been received from a spontaneous prospective pregnancy report, for VARIVAX (Merck), a Pregnancy Registry product, concerning a female patient of unknown age. On approximately 01-AUG-2013 ("about 4 or 5 weeks ago") the patient was vaccinated with VARIVAX (Merck), injection (lot#, expiration, and route unknown). It was reported that patient became pregnant "less than 2 weeks" after administration of VARIVAX (Merck). The patients LMP was approximately on 08-AUG-2013. The patient sought medical attention via office visit. Additional information has been requested.
3 days after receiving Moderna vaccine, patient developed multiple painful left cranial neuropathies. There has been evidence since onset of symptoms of left cranial nerve V1, V2, IV, and III palsies.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age. On 11-NOV-2013 the patient was vaccinated with ZOSTAVAX (dose unknown). Lot number was reported as J001729 and expiry date was 20-OCT-2013. The patient was administered an expired dose of ZOSTAVAX. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 03-JUN-2016, the patient was vaccinated with improperly stored doses of M-M-R II 0.5 ml injection, lot# L032181, expiry date: 25-AUG-2017 (route and site of administration were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 11.1 degrees Celsius for 1 hour and 36 minutes and also at a temperature of -12.3 degrees Celsius for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Second dose administered greater than 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Second dose administered greater than 12 hours post puncture) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.  The patient's past medical history included Hypertension since an unknown date. Concurrent medical conditions included Morbid obesity.On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Second dose administered greater than 12 hours post puncture). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Second dose administered greater than 12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and treatment medications were provided by reporter.
two weeks after shot I starting having pain in my right shoulder.  thought I over worked it, but week by week it continue to get worse.  To the point that it wakes me up 4-5 times a night.  While on vacation it hit a tipping point in pain and my pinky finger and ring finger started going numb on my hand.  I started to research and thought it might be a nerve issue... from top of shoulder blade to my fingers I get pain.  Pain to the point I have a hard time moving my arm in certain directions.  two day prior to returning from vacation I called the doctor to have it checked out. On July 12th I saw my doctor (knowing nothing about J&J) and he thought I just needed a steroid shot for inflammation and was given the shot.  watching news  I heard about these nerve issue with J&J, men over 50 and everything they were saying fit me perfect.  The next day I followed up with my doctor (Put a call into him) and a nurse called me back and informed me it probably had nothing to do with the J&J shot.    I called the location that gave me the shot and they recommend that I complete this from.  Today, 7/17/21 I am still in pain with numbness in my fingers.
Patient is a 84 y.o. male patient with PMHx of HTN, HLD, mild AR/AS, recently diagnosed covid-19 who presents to ED with increased shortness of breath who was found to be Covid-19 positive again with Acute pulmonary embolus with acute cor pulmonale and acute respiratory failure with hypoxia.   Acute provoked pulmonary embolus Acute respiratory failure with hypoxia Presented w SOB and and CP CT: moderate volume bilateral pulmonary emboli and suggestive of right heart strain Initially hypoxic requiring 2LNC- improved and was stable on RA  Started on iv heparin, Venous duplex: no DVT/SVT b/l 9/7 TTE shows LVEF 63%, no PHTN, cor pulmonale resolved Discussed with Interventional cardiology: no need for thrombectomy, due to hemodynamic stability Started eliquis 9/7, heparin gtt stopped Patient agreeable to $47 copay as outpatient Will need to be on Eliquis for 3months - RRT: pt did not qualify for home O2 - CM team: Home with HH    Covid-19 infection , lungs mostly CTAB ID following: was beyond timeframe for remdesivir, Dexamethasone until discharge - CM: pt agreeable to HHC  - PT: 2-3x/week, qualifying for HH - OT: no further therapy needed - Pt is requesting Hospital bed    Essential htn BP elevated 180's to 160's At home on metoprolol, hydrochlorothiazide and quinapril Metoprolol held prior to TTE, restarted Resumed home meds Feel elevated BPs is related to decadron - Hydralazine 10 mg IV PRN Q4 hrs for SBP>160.  Discussed close monitoring of vitals with nurse to ensure BP remains controlled - Amlodipine 5 mg will not be required at discharge - Better controlled BPs - Discharge with home meds  Aortic stenosis Aortic regurgitation 9/7 TTE - unchanged from prior TTE   Mixed hyperlipidemia Continue statin   Right lung nodule CT as above - f/u with PCP as outpatient for monitoring recommendations